Diagnosis and treatment of bronchial intraepithelial neoplasia and early lung cancer of the central airways: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Wisnivesky, Juan P ^a   Yung, Rex Chin Wei ^b   Mathur, Praveen N ^c   Zulueta, Javier J ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARCINOGEN; PHOTOFRIN II; TALAPORFIN;

ARTICLE; AUTOFLUORESCENCE BRONCHOSCOPY; AUTOFLUORESCENCE IMAGING; BRACHYTHERAPY; BRONCHIAL INTRAEPITHELIAL NEOPLASIA; BRONCHOSCOPIC ELECTROCAUTERY; BRONCHOSCOPY; BRONCHUS CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CARCINOMA IN SITU; CAUTERIZATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DISEASE SEVERITY; EARLY CANCER; EARLY CENTRAL LUNG CANCER; EVIDENCE BASED MEDICINE; FOLLOW UP; HISTORY; HUMAN; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; LASER SURGERY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG DYSPLASIA; LUNG SQUAMOUS CELL CARCINOMA; NARROW BAND IMAGING; NEODYMIUM YAG LASER; OCCUPATIONAL EXPOSURE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; SECOND CANCER; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM CYTODIAGNOSIS; SYNCHRONOUS LUNG CANCER; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR INVASION; TUMOR LOCALIZATION;

EID: 84877651459     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2358     Document Type: Article

References (107)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): 41S-50S.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59 (4): 225-249.
3. Ishizumi T, McWilliams A, MacAulay C, Gazdar A, Lam S. Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev. 2010; 29 (1): 5-14.
4. Kennedy TC, McWilliams A, Edell E, et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):221S-233S.
5. Travis W, Colby T, Corrin B, eds. Histological Typing of Lung and Pleural Tumours. WHO International Histological Classification of Tumours. 3rd ed. Berlin, Germany: Springer; 1999.
6. Keith RL, Miller YE, Gemmill RM, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res. 2000; 6(5):1616-1625.
7. Nicholson AG, Perry LJ, Cury PM, et al. Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intraobserver variation. Histopathology. 2001; 38 (3): 202-208.
8. Venmans BJ, van der Linden HC, Elbers HR, et al. Observer variability in histopathologic reporting of bronchial biopsy specimens: influence on the results of autofluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Journal of Bronchol. 2000; 7 (3): 210-214.
9. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer. 1974; 33 (1): 256-270.
10. Frost JK, Ball WC Jr, Levin ML, et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med. 1986; 28 (8): 692-703.
11. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005; 11(2 pt 1):537-543.
12. Siegfried JM. Biology and chemoprevention of lung cancer. Chest. 1998; 113 (suppl 1): 40S-45S.
13. Sato M, Saito Y, Usuda K, Takahashi S, Sagawa M, Fujimura S. Occult lung cancer beyond bronchoscopic visibility in sputum-cytology positive patients. Lung Cancer. 1998; 20(1): 17-24.
14. Bechtel JJ, Kelley WR, Petty TL, Patz DS, Saccomanno G. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch Intern Med. 1994; 154 (9): 975-980.
15. Woolner LB, Fontana RS, Cortese DA, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984; 59 (7): 453-466.
16. Lam S, MacAulay C, Hung J, LeRiche J, Profio AE, Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg. 1993; 105 (6): 1035-1040.
17. Lam S, Hung JY, Kennedy SM, et al. Detection of dysplasia and carcinoma in situ by ratio fluorometry. Am Rev Respir Dis. 1992; 146 (6): 1458-1461.
18. Sun J, Garfield DH, Lam B, et al. The value of autofluorescence bronchoscopy combined with white light bronchoscopy compared with white light alone in the diagnosis of intraepithelial neoplasia and invasive lung cancer: a metaanalysis. J Thorac Oncol. 2011; 6(8):1336-1344.
19. Weigel TL, Kosco PJ, Dacic S, Yousem S, Luketich JD. Fluorescence bronchoscopic surveillance in patients with a history of non-small cell lung cancer. Diagn Ther Endosc. 1999; 6 (1): 1-7.
20. Moro-Sibilot D, Jeanmart M, Lantuejoul S, et al. Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy. Chest. 2002; 122 (6): 1902-1908.
21. Häussinger K, Becker H, Stanzel F, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax. 2005; 60 (6): 496-503.
22. Chhajed PN, Shibuya K, Hoshino H, et al. A comparison of video and autofluorescence bronchoscopy in patients at high risk of lung cancer. Eur Respir J. 2005; 25(6):951-955.
23. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst. 2001; 93 (18): 1385-1391.
24. Kurie JM, Lee JS, Morice RC, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst. 1998; 90 (13): 991-995.
25. Venmans BJ, Van Boxem TJ, Smit EF, Postmus PE, Sutedja TG. Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn Ther Endosc. 1999; 5 (2): 77-84.
26. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest. 1998; 113 (3): 696-702.
27. Lam S, Macaulay C, Leriche JC, Ikeda N, Palcic B. Early localization of bronchogenic carcinoma. Diagn Ther Endosc. 1994; 1 (2): 75-78.
28. Sato M, Sakurada A, Sagawa M, et al. Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening. Lung Cancer. 2001; 32 (3): 247-253.
29. Vermylen P, Pierard P, Roufosse C, et al. Detection of bronchial preneoplastic lesions and early lung cancer with fluores-cence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis. Lung Cancer. 1999; 25 (3): 161-168.
30. Kusunoki Y, Imamura F, Uda H, Mano M, Horai T. Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry. Chest. 2000; 118 (6): 1776-1782.
31. Edell E, Lam S, Pass H, et al. Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial. J Thorac Oncol. 2009; 4(1):49-54.
32. Ueno K, Kusunoki Y, Imamura F, et al. Clinical experience with autofluorescence imaging system in patients with lung cancers and precancerous lesions. Respiration. 2007; 74(3):304-308.
33. Ikeda N, Hiyoshi T, Kakihana M, et al. Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancer. Lung Cancer. 2003; 41 (3): 303-309.
34. Chiyo M, Shibuya K, Hoshino H, et al. Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system. Lung Cancer. 2005; 48 (3): 307-313.
35. Kakihana M, Il KK, Okunaka T, et al. Early detection of bronchial lesions using System of Autofluorescence Endoscopy (SAFE) 1000. Diagn Ther Endosc. 1999; 5 (2): 99-104.
36. Yokomise H, Yanagihara K, Fukuse T, et al. Clinical experience with lung-imaging fluorescence endoscope (LIFE) in patients with lung cancer. J Bronchology. 1997; 4(3): 205-208.
37. Venmans BJ, van der Linden H, van Boxem T, Postmus P, Smit E, Sutedja T. Early detection of preinvasive lesions in high-risk patients: a comparison of conventional flexible and fluorescence bronchoscopy. Journal of Bronchology. 1998; 5 (4): 280-283.
38. Ernst A, Simoff MJ, Praveen NM, Rex CY, Beamis JF. D-light autofluorescence in the detection of premalignant airway changes: a multicenter trial. Journal of Bronchology. 2005; 12 (3): 133-138.
39. Ikeda N, Honda H, Hayashi A, et al. Early detection of bronchial lesions using newly developed videoendoscopybased autofluorescence bronchoscopy. Lung Cancer. 2006; 52 (1): 21-27.
40. Ikeda N, Honda H, Katsumi T, et al. Early detection of bronchial lesions using lung imaging fluorescence endoscope. Diagn Ther Endosc. 1999; 5:85-90.
41. van Rens MT, Schramel FM, Elbers JR, Lammers JW. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer. Lung Cancer. 2001; 32 (1): 13-18.
42. Helfritzsch H, Junker K, Bartel M, Scheele J. Differentiation of positive autofluorescence bronchoscopy findings by comparative genomic hybridization. Oncol Rep. 2002; 9 (4): 697-701.
43. Herth FJ, Ernst A, Becker HD. Autofluorescence bronchoscopy-a comparison of two systems (LIFE and D-Light). Respiration. 2003; 70(4):395-398.
44. Pierard P, Martin B, Verdebout J, et al. Fluorescence bronchoscopy in high-risk patients: a comparison of LIFE and Pentax systems. Journal of Bronchology. 2001; 8 (4): 254-259.
45. Shibuya K, Hoshino H, Chiyo M, et al. High magnification bronchovideoscopy combined with narrow band imaging could detect capillary loops of angiogenic squamous dysplasia in heavy smokers at high risk for lung cancer. Thorax. 2003; 58 (11): 989-995.
46. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991; 254 (5035): 1178-1181.
47. Herth FJ, Eberhardt R, Anantham D, Gompelmann D, Zakaria MW, Ernst A. Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection. J Thorac Oncol. 2009; 4(9):1060-1065.
48. Bojan Z, Branislav P, Aleksandra J, et al. Influence of narrow band imaging (NBI) videobronchoscopy on the assessment of central lung cancer extension and therapeutic decision. Cancer Invest. 2009; 27 (9): 918-923.
49. Lam S, Standish B, Baldwin C, et al. In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res. 2008; 14(7):2006-2011.
50. Alaa M, Shibuya K, Fujiwara T, et al. Risk of lung cancer in patients with preinvasive bronchial lesions followed by autofluorescence bronchoscopy and chest computed tomography. Lung Cancer. 2011; 72 (3): 303-308.
51. Bota S, Auliac JB, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med. 2001; 164 (9): 1688-1693.
52. Moro-Sibilot D, Fievet F, Jeanmart M, et al. Clinical prognostic indicators of high-grade pre-invasive bronchial lesions. Eur Resp J. 2004; 24(1):24-29.
53. Jeanmart M, Lantuejoul S, Fievet F, et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res. 2003; 9(6): 2195-2203.
54. Hoshino H, Shibuya K, Chiyo M, et al. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer. 2004; 46 (2): 187-196.
55. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja TG. Outcome of bronchial carcinoma in situ. Chest. 2000; 117 (6): 1572-1576.
56. Jeremy George P, Banerjee AK, Read CA, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax. 2007; 62 (1): 43-50.
57. Salaün M, Sesboüé R, Moreno-Swirc S, et al. Molecular predictive factors for progression of high-grade preinvasive bronchial lesions. Am J Respir Crit Care Med. 2008; 177 (8): 880-886.
58. Lam S, MacAulay C, Le Riche JC, et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst. 2002; 94 (13): 1001-1009.
59. Kennedy TC, Franklin WA, Prindiville SA, et al. High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum. Chest. 2004; 125(suppl 5): 109S.
60. Lam S, leRiche JC, McWilliams A, et al. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res. 2004; 10 (19): 6502-6511.
61. van Boerdonk RA, Sutedja TG, Snijders PJ, et al. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer. Am J Respir Crit Care Med. 2011; 184 (8): 948-956.
62. Jeanmart M, Lantuejoul S, Fievet F, et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res. 2003; 9 (6): 2195-2203.
63. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005; 11 (2 pt 1): 537-543.
64. Banerjee AK. Preinvasive lesions of the bronchus. J Thorac Oncol. 2009; 4 (4): 545-551.
65. Prindiville SA, Byers T, Hirsch FR, et al. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. Cancer Epidemiol Biomarkers Prev. 2003; 12(10):987-993.
66. Varella-Garcia M, Schulte AP, Wolf HJ, et al. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila). 2010; 3 (4): 447-453.
67. Tockman MS, Gupta PK, Myers JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol. 1988; 6(11):1685-1693.
68. Risse EK, Vooijs GP, van't Hof MA. Diagnostic signifi-cance of "severe dysplasia" in sputum cytology. Acta Cytol. 1988; 32 (5): 629-634.
69. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy. Lung Cancer. 2001; 32 (1): 19-25.
70. Kennedy TC, Franklin WA, Prindiville SA, et al. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia. Lung Cancer. 2005; 49 (2): 187-191.
71. Lam B, Lam SY, Wong MP, et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009; 64 (3): 289-294.
72. McWilliams A, Mayo J, MacDonald S, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med. 2003; 168 (10): 1167-1173.
73. Ikeda N, Honda H, Katsumi T, et al. Early detection of bronchial lesions using lung imaging fluorescence endscope. Diagn Ther Endosc. 1999; 5(2):85-90.
74. Bach PB, Silvestri GA, Hanger M, et al. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):69S-77S.
75. Piérard P, Faber J, Hutsebaut J, et al. Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airways. Lung Cancer. 2004; 46 (3): 341-347.
76. Pierard P, Vermylen P, Bosschaerts T, et al. Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer. Chest. 2000; 117(3): 779-785.
77. Lam S. Photodynamic therapy of lung cancer. Semin Oncol. 1994; 21 (6 suppl 15): 15-19.
78. Sutedja TG, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest. 2001; 120 (4): 1327-1332.
79. Vincent BD, Fraig M, Silvestri GA. A pilot study of narrowband imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest. 2007; 131 (6): 1794-1799.
80. Zaric B, Perin B, Becker HD, et al. Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension. Med Oncol. 2012; 29 (3): 1638-1642.
81. Zaric B, Becker HD, Perin B, et al. Narrow band imaging videobronchoscopy improves assessment of lung cancer extension and influences therapeutic strategy. Jpn J Clin Oncol. 2009; 39 (10): 657-663.
82. Pérol M, Caliandro R, Pommier P, et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest. 1997; 111 (5): 1417-1423.
83. van Boxem TJ, Venmans BJ, Schramel FM, et al. Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J. 1998; 11(1):169-172.
84. Deygas N, Froudarakis M, Ozenne G, Vergnon JM. Cryotherapy in early superficial bronchogenic carcinoma. Chest. 2001; 120 (1): 26-31.
85. Cavaliere S, Foccoli P, Toninelli C, Feijo S. Nd: YAG laser therapy in lung cancer: an 11-year experience with 2,253 applications in 1,585 patients. Journal of Bronchology. 1994; 1 (2): 105-111.
86. Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Kanoh K, Kohno N. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med. 2002; 165 (6): 832-837.
87. Kato H, Okunaka T, Shimatani H. Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Med Surg. 1996; 14 (5): 235-238.
88. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 1997; 72 (7): 595-602.
89. Kato H, Usuda J, Okunaka T, et al. Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital. Lasers Surg Med. 2006; 38 (5): 371-375.
90. Moghissi K, Dixon K, Thorpe JA, Stringer M, Oxtoby C. Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax. 2007; 62 (5): 391-395.
91. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol. 1993; 11(10):1852-1857.
92. Patelli M, Lazzari Agli L, Poletti V, Falcone F. Photodynamic laser therapy for the treatment of early-stage bronchogenic carcinoma. Monaldi Arch Chest Dis. 1999; 54(4):315-318.
93. Sutedja T, Baas P, Stewart F, van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer. Eur J Cancer. 1992; 28A(8-9): 1370-1373.
94. Radu A, Grosjean P, Fontolliet C, et al. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagn Ther Endosc. 1999; 5 (3): 145-154.
95. Cortese DA, Kinsey JH. Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. Chest. 1984; 86 (1): 8-13.
96. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc. 1987; 62 (1): 8-14.
97. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest. 1992; 102(5): 1319-1322.
98. Kato H, Furukawa K, Sato M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer. 2003; 42 (1): 103-111.
99. Hennequin C, Bleichner O, Trédaniel J, et al. Long-term results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys. 2007; 67 (2): 425-430.
100. Marsiglia H, Baldeyrou P, Lartigau E, et al. High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 2000; 47 (3): 665-672.
101. Konaka C, Hirano T, Kato H, et al. Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings. Br J Cancer. 1999; 80 (9): 1435-1439.
102. Fujimura S, Sakurada A, Sagawa M, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer. 2000; 89 (suppl 11): 2445-2448.
103. Nakamura H, Kawasaki N, Hagiwara M, Ogata A, Kato H. Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung. Cancer. 2001; 91 (6): 1142-1147.
104. Kurimoto N, Murayama M, Yoshioka S, Nishisaka T, Inai K, Dohi K. Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion. Chest. 1999; 115 (6): 1500-1506.
105. Ikeda N, Usuda J, Kato H, et al. New aspects of photodynamic therapy for central type early stage lung cancer. Lasers Surg Med. 2011; 43 (7): 749-754.
106. Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982; 81 (3): 269-277.
107. Sutedja T, Lam S, LeRiche JC, et al. Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchology Interv Pulmonol. 1994; 1 (4): 295-298.